c Taxonomic classification of Clostridium botulinum is based on the production of botulinum neurotoxin (BoNT), while closely related, nontoxic organisms are classified as Clostridium sporogenes. However, this taxonomic organization does not accurately mirror phylogenetic relationships between these species. A phylogenetic reconstruction using 2,016 orthologous genes shared among strains of C. botulinum group I and C. sporogenes clearly separated these two species into discrete clades which showed Ïł93% average nucleotide identity (ANI) between them. Clustering of strains based on the presence of variable orthologs revealed 143 C. sporogenes clade-specific genetic signatures, a subset of which were further evaluated for their ability to correctly classify a panel of presumptive C. sporogenes strains by PCR. Genome sequencing of several C. sporogenes strains lacking these signatures confirmed that they clustered with C. botulinum strains in a core genome phylogenetic tree. Our analysis also identified C. botulinum strains that contained C. sporogenes clade-specific signatures and phylogenetically clustered with C. sporogenes strains. The genome sequences of two bont/B2-containing strains belonging to the C. sporogenes clade contained regions with similarity to a bont-bearing plasmid (pCLD), while two different strains belonging to the C. botulinum clade carried bont/B2 on the chromosome. These results indicate that bont/B2 was likely acquired by C. sporogenes strains through horizontal gene transfer. The genome-based classification of these species used to identify candidate genes for the development of rapid assays for molecular identification may be applicable to additional bacterial species that are challenging with respect to their classification.
Botulinum neurotoxins (BoNT) cause neuromuscular paralysis associated with botulism and are produced by various clostridia, most notably Clostridium botulinum. C. botulinum is a Gram-positive, anaerobic, endospore-forming bacillus that can be classified on the basis of metabolic properties into four separate groups (groups I to IV). Group I C. botulinum strains are proteolytic, saccharolytic, and capable of producing BoNT types A, B, and F. Group II C. botulinum strains are nonproteolytic and can produce BoNT types B, E, and F, while group III strains produce BoNT types C and D. Group IV strains, which are also identified as Clostridium argentinense, produce BoNT type G.The nontoxic species Clostridium sporogenes shares nearly identical metabolic properties with group I C. botulinum, including the formation of lipase-positive colonies when grown on egg yolk agar. Because of these similarities and the comparable heat resistance of its spores, C. sporogenes has been used as a surrogate organism for C. botulinum in the study of thermal processing for foods (1). Previous studies have shown that some strains of C. sporogenes and group I C. botulinum can be differentiated phenotypically by soluble protein expression, measured by polyacrylamide gel electrophoresis (2) and ga...